Candidiasis, also known as yeast overgrowth or yeast infection, is a growing problem. At least 80 million people are estimated to suffer from the health symptoms of yeast overgrowth. However, potentially millions more have the condition without realizing it. Many of those suffering from yeast overgrowth turn to probiotics to naturally relieve their symptoms. But, there is a more powerful solution. Syntol AMD combines the beneficial properties of probiotics, prebiotics and enzymes to not only kill yeast but also keep them from multiplying unchecked in the first place.
Candidiasis is a byproduct of our modern lives
There are actually more than 20 different types of Candida that live on the many surfaces of your body. Usually, though, your immune system keeps these potentially harmful yeasts in check. However, using antibiotics, eating a poor diet and a number of other factors can disrupt the natural balance and allow Candida to multiply unchecked [1,2]. Eventually there are so many of these yeasts that they basically turn into parasites, robbing our bodies of important resources for their own benefit.
Because Candida, like all fungi, thrive in warm, moist environments, candidiasis is most likely to occur in areas like the mouth, vagina and intestines. Candida overgrowth that causes white patches to form in your mouth is usually called thrush, whereas Candidiasis in the vagina is generally known as a yeast infection.
Syntol AMD is the first and only gentle yeast cleanse of its kind
Syntol’s unique combination of probiotics, prebiotics and enzymes work together to eliminate Candida from all angles, restoring the body’s natural balance.
Syntol AMD contains 3.4 billion good bacteria, which are from eight different strains of probiotic bacteria that do not compete with each other:
- Bacillus subtilis
- Lactobacillus helvecticus
- Saccharomyces boulardii
- Lactobacillus acidophilus
- Lactobacillus rhamnosus
- Lactobacillus plantarum
- Lactobacillus lactis
- Bifidobacterium bifidum
Probiotics are good bacteria that boost health when they are taken orally and are allowed to grow and multiply in the body . Bacteria from the Lactobacillus andBifidobacterium families are especially well known for being able to resist digestion by gastric acid, bile salts and pancreatic enzymes and go on to grow and multiply in the GI tract . Oral lactobacillus supplements have also been shown to increase the numbers of lactobacilli in the vagina .
B. subtilis is especially suited for colonizing the gastrointestinal tract because it is a spore-forming bacteria. Most bacteria are susceptible to any acidic pH range, mainly thriving in the more alkaline lower GI, but spores are able to withstand a broader range of variables in regards to pH and temperature ranges. This improves the chances that the probiotic strain will properly colonize the GI tract.
Using probiotics to kill yeast is not a new idea. Various strains of probiotic bacteria, including members of the lactobacillus family, have been used for years in the manufacturing process as anactive preservative against yeast . This is because probiotics produce a number of different compounds that can kill yeasts, like hydrogen peroxide [7-9].
Yeast thrives in environments without a lot of oxygen. By producing hydrogen peroxide, the probiotics in Syntol create an extremely oxygen-rich environment, which acts like a poison, effectively killing the excessive yeast. Once the yeast is gone, this oxygen-rich environment provides the ideal growing conditions for healthy bacteria, which reestablishes a healthy balance in the body.
The protective effects of probiotics is also due to the fact that they compete for space on the lining of the GI tact, mouth and vagina [7,8,10,11]. If the yeasts can’t attach themselves to a stable surface, they can’t grow and multiply. Finally, probiotics boost the immune system, enhancing the body’s innate ability to fight against Candida overgrowth [8,12-15].
Because of these effects in the body, studies have shown that oral probiotics can suppress the growth of Candida in the intestines, as well as effectively treat thrush in the elderly and vaginal yeast infections in women [16-21]. There is also evidence that taking probiotics can help protect against any future recurrences of Candidiasis .
Syntol AMD maximizes the potential of its probiotic formula by combining it with the prebiotic inulin. Inulin is a type of fiber that can’t be digested by the body. In fact, around 87% of the inulin you ingest remains completely intact after going through both your stomach and small intestine . This undigested inulin helps promote the growth and activity of good bacteria in your gut, especially those from the bifidobacteriumand lactobacillusfamilies,while having a neutral or negative effect on any harmful organisms (like Candida) that might be living there [24-26]. Some studies have also suggested that prebiotics may pull harmful organisms away from the lining of your intestines .
Candida albicans, the most common type of Candida, is often difficult to kill because it is surrounded by a protective outer layer. Under this shell, Candida is mainly made up of cellulose and N-acetyl-glucosamine, which provides additional protection . Syntol contains an extremely potent blend of enzymes that digest proteins, cellulose and sugars, to strip away Candida’s protective outer covering and digest its cells inside. These enzymes also help remove any dead yeast or other disease-causing bacteria from your body. This helps protect you from the detox symptoms that are usually triggered by the toxins given off during the elimination of yeast.
Syntol AMD provides gentle strength in the fight against Candidiasis
Syntol AMD is the only product on the market that combines prebiotics, probiotics and an enzyme blend into one capsule. This powerfulcombination of ingredients not only kills Candida but also removes dead yeast and other unwanted debris from the body, making Syntol AMD much stronger than any other yeast cleanse. However, despite this strength, Syntol AMD who’s natural ingredients have a very low risk of side effects so you can use it with confidence to prevent and treat Candidiasis.
Buy Syntol AMD
Soll DR, Morrow B, Srikantha T. High-frequency phenotypic switching in Candida albicans. Trends Genet. 1993;9:61-65.
Perisic DV, Dokic M, Kovacevic G. The role of probiotics and prebiotics in female health. Arch Gastroenterohepatol. 2003;22(3-4):79-83.
Fiaromonti J, Theodoru V, Bueno. Probiotics: what are they? What are their effects on gut physiology. Best Practice Res Clin Gastroenterol. 2003;17:711-724.
Marteau P, Shanahhan F.Basic aspect and pharmacology of probiotics: an overview of pharmacokinetics, mechanisms of action and side-effects. Best Practice Res Clin Gastroenterol. 2003;17:725-740.
Reid G, Charbonneau D, Erb J, et al. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immun Med Microbiol. 2003;35:131-134.
Suomalainen TH, Mäyrä-Mäkinen AM. Propionic acid bacteria as protective cultures in fermented milks and breads. Lait. 1999;79:165-174.
Strus M, Kucharska A, Kukla G, Brzychczy-Wloch M, Maresz K, Heczko PB. The in vitroactivity of vaginal Lactobacillus with probiotic properties against Candida. Infect Dis Obstet Gynecol. 2005;13:69-75.
de Verse M, Schrezenmeeir J. Probiotics and non-intestinal infectious conditions Br J Nutr. 2002;88(Suppl 1):S59-66.
Ström K, Sjögren J, Broberg A, Schnurer J. Lactobacillus plantarumMiLAB 393 produces the antifungal cyclic dipeptidescyclo(L-Phe-L-Pro) and cyclo(L-Phe-trans-4-OH-L-Pro) and 3-phenyllactic acid. Appl Environ Microbiol. 2002;68:4322-4327.
Reid GR, Burton J.Use of Lacobacillus to prevent infection by pathogenic bacteria. Microbes Infect. 2002;4:319-324.
Reid G, Tieszer C, Lam D. Influence of lactobacilli on the adhesion of Staphylococcus aureus and Candida albicansto fibers and epithelial cells. J Ind Microbiol. 1995;15:248-253.
Arunachalam K, Gill HS, Chandra RK. Enhancement of natural immune function by dietary consumption of Bifidobacterium lactis(HN019). Eur J Clin Nutr. 2000;54:263-267.
Gill HS, Rutherfurd KJ, Cross ML (2001). Dietary probiotic supplementation enhances natural killer cell activity in the elderly: an investigation of age-related immunological changes. J Clin Immunol 21:264-271.
Elahi S, Pang G, Ashman R, Clancy R. Enhanced clearance of Candida albicansfrom the oral cavities of mice following oral administration of Lactobacillus acidophilus. Clin Exp Immunol. 2005;141:29-36.
Brzozowski T, Zwolinska-Wcislo M, Konturek PC, et al. Influence of gastric colonization with Candida albicanson ulcer healing in rats: effect of ranitidine, aspirin and probiotic therapy. Scand J Gastroenterol. 2005;40:286-296.
Manzoni P, Mostert M, Leonessa ML, et al. Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: a randomized study. Clin Infect Dis. 2006;42:1735-1742.
Payne S, Gibson G, Wynne A, Hudspith B, Brostoff J, Tuohy K. In vitro studies on colonization resistance of the human gut microbiota to Candida albicans and the effects of tetracycline and Lactobacillus plantarum LPK. Curr Issues Intest Microbiol. 2003;4:1-8.
Hatakka K, Ahola AJ, Yli-Knuuttila H, et al. Probiotics reduce the prevalence of iral Candida in the elderly—a randomized controlled trial. J Dent Res. 2007;86(2):125-130.
Reid G, Bruce A, Fraser N, et al. Oral probiotics can resolve urogenital infections. FEMS Immun Med Microbiol. 2001;30:49-52.
Reid G, Beuerman D, Heinemann C, et al. Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS Immun Med Microbiol. 2001;32:37-41.
Hilton E, Isenberg HD, Alperstein P. Ingestion of yogurt containing Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med. 1992;116:353-357.
Balish E, Wagner RD. Probiotic bacteria for prophylaxis and therapy of candidiasis. Rev Iberoam Micol. 1998;15:261-264.
Perisic VN, Medic I. Basic aspects of pre-, pro- and synbiotics. Arch Gastroenterohepatol. 2003;22(3-4):65-72.
Borriello SP.Microbial flora of the gastrointestinal tract. In: Hill MJ, ed. Microbial metabolism in the digestive tract. Boca Raton, FL: CRC Press, 1986:2-16.
Gibson GR, Fuller R. Aspects of in vivo and vitro research approaches directed toward identifying probiotics and prediotics in human use. J Nutr. 2000;130:391S-395S.
Rastall RA, Maitin V. Prebiotics and synbiotics: towards the next generation. Curr Opin Biotechnol. 2002;13:490-496.
Gibson GR, Roberfroid MB.Dietary manipulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr. 1995;125:1401-1479.
Lipke PN, Ovalle R. Cell wall architecture in yeast: new structure and new challenges. J Bacteriol. 1998;180(15):3735-3740.